0001225208-24-006287.txt : 20240521
0001225208-24-006287.hdr.sgml : 20240521
20240521170941
ACCESSION NUMBER: 0001225208-24-006287
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240521
FILED AS OF DATE: 20240521
DATE AS OF CHANGE: 20240521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ullem Scott B.
CENTRAL INDEX KEY: 0001446989
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15525
FILM NUMBER: 24970592
MAIL ADDRESS:
STREET 1: C/O EDWARDS LIFESCIENCES CORPORATION
STREET 2: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edwards Lifesciences Corp
CENTRAL INDEX KEY: 0001099800
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 364316614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
BUSINESS PHONE: 9492502500
MAIL ADDRESS:
STREET 1: ONE EDWARDS WAY
CITY: IRVINE
STATE: CA
ZIP: 92614
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP.
DATE OF NAME CHANGE: 20090225
FORMER COMPANY:
FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP
DATE OF NAME CHANGE: 20000203
FORMER COMPANY:
FORMER CONFORMED NAME: CVG CONTROLLED INC
DATE OF NAME CHANGE: 19991126
4
1
doc4.xml
X0508
4
2024-05-21
0001099800
Edwards Lifesciences Corp
EW
0001446989
Ullem Scott B.
ONE EDWARDS WAY
IRVINE
CA
92614
1
CVP, Chief Financial Officer
1
Common Stock
2024-05-21
4
M
0
5625.0000
45.2767
A
36186.0000
D
Common Stock
2024-05-21
4
S
0
5625.0000
90.4539
D
30561.0000
D
Common Stock
266318.0000
I
By Trust
Employee Stock Option (Right to Acquire)
45.2767
2024-05-21
4
M
0
5625.0000
0.0000
D
2019-05-17
2025-05-16
Common Stock
5625.0000
61875.0000
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2024.
This transaction was executed in multiple trades at prices ranging from $90.225 to $90.720. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.
Linda J. Park, Attorney-in-Fact
2024-05-21